Mark Borodkin, Chief Operating Officer at BioNano Genomics, Inc (BNGO), bought 815 shares at $6.13 ($5K) on 2018-08-23, disclosed to the SEC on 2018-08-27.
Open-market purchase of $5k BNGO by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.